APOA1 and steatosis: Administration of apolipoprotein A-I alone also has a significant impact on body weight as has been previously reported (Ruan et al., 2011) and on liver weight, indicating that the apolipoprotein A-I moiety is the major driver of the effects on body weight and steatosis.